coincide with induced tumor proliferation A rationale for sequential high-dose chemotherapy of leukemia timed to

[1]  J. Karp,et al.  Long chemotherapy‐free remissions after single‐cycle timed‐sequential chemotherapy for acute myelocytic leukemia , 1980, Cancer.

[2]  F. Baker,et al.  Mechanism of action of serum factors that regulate granulopoiesis in vitro: possible physiologic role of serum-inhibiting activity. , 1979, Blood.

[3]  R. Slavin,et al.  Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols. A clinical‐pathologic study of 33 patients , 1978, Cancer.

[4]  H. Broxmeyer,et al.  Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production , 1978, The Journal of experimental medicine.

[5]  H. Broxmeyer,et al.  Role for monocyte-macrophage-derived colony-stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation. , 1978, Blood.

[6]  P. Quesenberry,et al.  Inhibition of normal murine hematopoiesis by leukemic cells. , 1978, The New England journal of medicine.

[7]  T. Olofsson,et al.  Inhibitor of hematopoietic cell proliferation derived from a human leukemic cell line. , 1978, Blood.

[8]  H. Broxmeyer.  Inhibition in vivo of mouse granulopoiesis by cell-free activity derived from human polymorphonuclear neutrophils. , 1978, Blood.

[9]  H. Broxmeyer,et al.  In vitro suppression of normal granulocytic stem cells by inhibitory activity derived from human leukemia cells. , 1978, Journal of the National Cancer Institute.

[10]  J. Karp,et al.  Timed sequential therapy of human leukemia based upon the response of leukemic cells to humoral growth factors. , 1977, Cancer research.

[11]  J. Karp,et al.  Induction of serum stimulation and plasma cell proliferation during chemotherapy of multiple myeloma. , 1977, Blood.

[12]  F. Valeriote,et al.  Cellular quantitation of in vivo effects of 1-beta-D-arabinofuranosylcytosine on leukemia L1210. , 1977, Journal of the National Cancer Institute.

[13]  A. Hagenbeek,et al.  Proliferation kinetics of the BNML leukaemia in vivo , 1977 .

[14]  S. Knudtzon,et al.  Interaction between normal and leukaemic human cells in agar culture. , 2009, Scandinavian journal of haematology.

[15]  J. Karp,et al.  Enhancement of drug cytotoxicity by recruitment of leukemic myeloblasts with humoral stimulation. , 1976, Cancer research.

[16]  D. V. van Bekkum,et al.  In vitro colony formation of transplantable rat leukemias in comparison with human acute myeloid leukemia. , 1976, Cancer research.

[17]  R. Young,et al.  Recovery of normal hematopoietic tissue and tumor following chemotherapeutic injury from cyclophosphamide (CTX): comparative analysis of biochemical and clinical techniques. , 1975, Blood.

[18]  R. Young,et al.  The effect of chemotherapy on the kinetics and proliferative capacity of normal and tumorous tissues in vivo , 1975 .

[19]  W. Robinson,et al.  The kinetics and regulation of granulopoiesis. , 1975, Seminars in hematology.

[20]  R. Momparler,et al.  A model for the chemotherapy of acute leukemia with 1-beta-D-arabinofuranosylcytosine. , 1974, Cancer research.

[21]  M. Moore,et al.  Responsiveness of human granulocytic leukemic cells to colony-stimulating factor. , 1974, Blood.

[22]  D. Groth,et al.  Correlation of cytosine arabinoside‐induced increment in growth fraction of leukemic blast cells with clinical response , 1974, Cancer.

[23]  D. Metcalf.  Stimulation by human urine or plasma of granulopoiesis by human marrow cells in agar. , 1974, Experimental hematology.

[24]  L. Sachs,et al.  Differences in Inducing Activity for Human Bone Marrow Colonies in Normal Serum and Serum From Patients With Leukemia , 1973 .

[25]  P. Burke,et al.  Factors in human serum affecting the proliferation of normal and leukemic cells. , 1973, Cancer research.

[26]  P. Schein,et al.  Enhanced antitumor effect of cytosine arabinoside given in a schedule dictated by kinetic studies in vivo. , 1973, Biochemical pharmacology.

[27]  G. Gahrton,et al.  Inhibitors of the bone‐marrow colony formation in sera of patients with leukemia , 1972, International journal of cancer.

[28]  B. Lampkin,et al.  Cell kinetics and chemotherapy in acute leukemia. , 1972, Seminars in hematology.

[29]  W. Dewys.  Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor-related systemic growth-retarding factors. , 1972, Cancer research.

[30]  D. Metcalf,et al.  Colony-stimulating factor and inhibitor levels in acute granulocytic leukemia. , 1971, Blood.

[31]  J. Till,et al.  Colony formation by normal and leukemic human marrow cells in culture: effect of conditioned medium from human leukocytes. , 1971, Blood.

[32]  H. H. Lloyd,et al.  Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules. , 1970, Cancer chemotherapy reports.

[33]  F. Schabel,et al.  Altered sensitivity of a hamster plasmacytoma to cytosine arabinoside (NSC-63878). , 1970, Cancer chemotherapy reports.

[34]  S Perry,et al.  Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy. , 1970, Cancer research.

[35]  I. Tannock.  A comparison of cell proliferation parameters in solid and ascites Ehrlich tumors. , 1969, Cancer research.

[36]  F. Schabel,et al.  Toxicity Studies in Mice Treated with 1-β-d-Arabinofuranosyl-cytosine (ara-C) , 1969 .

[37]  T. Rytömaa,et al.  Chalones and Cancer: Control of Cell Production in Rat Chloroleukaemia by means of the Granulocytic Chalone , 1968, Nature.

[38]  H. Skipper,et al.  Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells. , 1967, Cancer chemotherapy reports.

[39]  A. Goldin,et al.  Chemotherapy of leukemia L1210 in mice with 1-beta-d-arabinofuranosylcytosine hydrochloride. I. Influence of treatment schedules. , 1966, Cancer research.